Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphorylase b kinase regulatory subunit beta (PHKB) is one of four major subunits (alpha, beta, gamma, delta) forming the phosphorylase b kinase holoenzyme, responsible for activating glycogen phosphorylase by phosphorylation. The beta subunit primarily regulates the enzyme's activity via phosphorylation and is present in both muscle and liver isoforms. Deficiency or mutation of the PHKB gene impairs glycogen breakdown, leading to glycogen accumulation, glucose shortage, and associated clinical syndromes, most notably glycogen storage disease type IXb.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphorylase b kinase regulatory subunit beta (PHKB).